advertisement
Trials 10
Showing records 1 to 10 |
Display all abstracts in Trials98455 Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trialLi Y
Trials 2022; 23: 16
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trialLeung CKS; Ren ST
Trials 2022; 23: 45
98455 Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trialZhu L; Wang R
Trials 2022; 23: 16
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trialChan PPM; Wan KHN
Trials 2022; 23: 45
98455 Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trialYang X
Trials 2022; 23: 16
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trialWan KHN
Trials 2022; 23: 45
98455 Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trialJiang X
Trials 2022; 23: 16
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trialKam AKW; Lai GWK
Trials 2022; 23: 45
98455 Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trialLu T
Trials 2022; 23: 16
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trialChiu VSM; Ko MWL; Ko MWL; Yiu CKF; Yu MCY
Trials 2022; 23: 45
Issue 22-4
Change Issue
advertisement